Midodrine helps cirrhotic patients live longer, data show

08/8/2011 | Medscape (free registration)

Long-term treatment with midodrine in addition to standard medical care increased survival and improved ascites control for cirrhotic patients in a pilot study of 40 patients reported in the Journal of Hepatology. Patients in the treatment group had increases in average arterial pressure, urinary volume and urine sodium excretion, and demonstrated a drop in plasma renin activity and plasma aldosterone concentrations.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC